TONIX PHARMACEUTICALS HOLDIN (TNXP) Stock Balance Sheet
NASDAQ:TNXP - Nasdaq - US8902608475 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 28.23M | 24.95M | 120.20M | 178.70M | 77.10M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 6.67M | N/A | N/A | N/A | N/A | |||
| Inventories | 8.27M | 13.64M | N/A | N/A | N/A | |||
| Other Current Assets | 7.37M | 9.18M | 10.50M | 10.40M | 10.90M | |||
| Total Current Assets | 50.54M | 47.77M | 130.80M | 189.00M | 88.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 43.38M | 94.85M | 94.50M | 51.50M | 9.80M | |||
| Goodwill | 0.00 | 965.00K | N/A | N/A | N/A | |||
| Intangibles | 120.00K | 9.74M | N/A | 100.00K | 100.00K | |||
| Other Non-Current Assets | 951.00K | 1.13M | 400.00K | 300.00K | 200.00K | |||
| Total Non-Current Assets | 44.45M | 106.69M | 94.90M | 51.90M | 10.20M | |||
| TOTAL ASSETS | 94.99M | 154.46M | 225.70M | 240.90M | 98.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 2.82M | 2.35M | N/A | N/A | N/A | |||
| Accrued Expenses | 8.43M | 5.37M | 6.20M | 4.90M | 2.60M | |||
| Accounts Payable | 3.94M | 3.78M | 8.10M | 13.30M | 4.60M | |||
| Other Current Liabilities | N/A | 7.38M | 3.90M | 3.50M | 2.60M | |||
| Total Current Liabilities | 15.18M | 18.88M | 18.20M | 21.70M | 9.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 5.17M | 6.56M | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 425.00K | 23.49M | 300.00K | 500.00K | 700.00K | |||
| Total Non-Current Liabilities | 5.60M | 30.05M | 300.00K | 500.00K | 700.00K | |||
| TOTAL LIABILITIES | 20.78M | 48.93M | 18.50M | 22.20M | 10.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -708.59M | -600.66M | -470.00M | -359.80M | -267.50M | |||
| Additional Paid In Capital | 782.89M | 706.36M | 677.30M | 578.10M | 355.00M | |||
| Common Shares | 156.00K | 59.00K | 100.00K | 500.00K | 200.00K | |||
| Other Shareholders' Equity | -250.00K | -232.00K | -200.00K | -100.00K | -100.00K | |||
| Shares Outstanding | 155.63M | 1.83M | 12.20M | 2.50M | 1.00M | |||
| Tangible Book Value per Share | 0.48 | 51.76 | 16.98 | 87.44 | 87.50 | |||
| Total Shareholders' Equity | 74.21M | 105.53M | 207.20M | 218.70M | 87.60M | |||
| TOTAL LIABILITIES AND EQUITY | 94.99M | 154.46M | 225.70M | 240.90M | 98.20M | |||
| Statistics | ||||||||
| Debt/Equity | 0.07 | 0.06 | N/A | N/A | N/A | |||
| Current Ratio | 3.33 | 2.53 | 7.19 | 8.71 | 8.98 | |||
| Return On Assets (ROA) | -142.38% | -75.53% | -51.79% | -38.31% | -53.13% | |||
| Return On Equity (ROE) | -182.25% | -110.55% | -56.41% | -42.20% | -59.55% | |||
All data in USD , ROIC based on taxRate of 0.21